80
Participants
Start Date
October 22, 2021
Primary Completion Date
February 17, 2023
Study Completion Date
June 21, 2023
Pfs230D1-EPA/Matrix-M Vaccine
Each single-use vial of Pfs230D1M-EPA contains 160 µg/mL of conjugated Pfs230D1M and 124 µg/mL or 143 µg/mL of conjugated EPA in 4 mM phosphate-buffered saline (PBS), in a volume of 0.5 mL. Each vial of Matrix-M1 contains saponin content of 0.375 mg/mL in PBS, at a pH of 7.2, in a final volume of 0.75 mL. Components will be combined in volumes defined in the protocol at point of use.
Verorab Rabies Vaccine
Verorab Rabies Vaccine is a purified inactivated rabies vaccine (Wistar rabies PM/WI 38 1503-3M strain) prepared on Vero cells. It is supplied as a powder and solvent for suspension for injection in a prefilled syringe. Before reconstitution, the powder is a white and homogeneous pellet. The solvent is a limpid solution.
Malaria Research Training Center, Bamako
Collaborators (1)
Novavax
INDUSTRY
Malaria Research and Training Center, Bamako, Mali
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH